Raisio - Company Announcement

RAISIO AND UNILEVER AGREE ON CROSS-LICENSING

Raisio plc  Stock Exchange Release 21 December 2007                             

RAISIO AND UNILEVER AGREE ON CROSS-LICENSING                                    

Raisio plc and Unilever have agreed on partial cross-licensing and thereby      
granting non-exclusive rights to the global plant sterol and stanol patents     
defined between the companies. This agreement is a conclusion to the opposition 
proceedings between the companies.                                              

Matti Rihko, CEO of Raisio, considers this an important agreement. “This        
agreement strengthens significantly the IPR-portfolio that is the base of the   
Benecol business. The cross-licensing agreement with Unilever is an indication  
of Raisio's high-quality, internationally acknowledged research and development 
of the Benecol ingredient. This agreement guarantees that both parties can      
concentrate on developing their business and applications instead of defending  
their patent portfolios in opposition proceedings.”                             

RAISIO PLC                                                                      

Heidi Hirvonen                                                                  
Communications Manager                                                          
tel. +358 2 443 2242 or +358 50 567 3060                                        

Further information:                                                            
Matti Rihko, CEO, tel. +358 400 830 727     



Distribution                                                                    
OMX Nordic Exchange, Helsinki                                                   
Key media                                                                       
www.raisio.com